Stelara Side Effects
Generic name: ustekinumab
Note: This document contains side effect information about ustekinumab. Some of the dosage forms listed on this page may not apply to the brand name Stelara.
Some side effects of Stelara may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to ustekinumab: subcutaneous solution
Along with its needed effects, ustekinumab (the active ingredient contained in Stelara) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking ustekinumab:More common
- Cough or hoarseness
- fever or chills
- lower back or side pain
- painful or difficult urination
- Body aches or pain
- difficulty with breathing
- ear congestion
- loss of voice
- nasal congestion
- runny nose
- sore throat
- unusual tiredness or weakness
- Blurred or loss of vision
- clear or bloody discharge from the nipple
- difficult or frequent urination
- dimpling of the breast skin
- disturbed color perception
- double vision
- halos around lights
- inverted nipple
- itching, pain, redness, swelling, tenderness, or warmth on the skin
- lump in the breast or under the arm
- night blindness
- overbright appearance of lights
- persistent crusting or scaling of the nipple
- redness or swelling of the breast
- sore on the skin of the breast that does not heal
- tunnel vision
- Difficulty with swallowing
- fast heartbeat
- hives or welts
- large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- redness of the skin
- shortness of breath
- tightness in the chest
Some side effects of ustekinumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:More common
- Muscle aches
- Back pain
- bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
- difficulty with moving
- joint pain
- muscle cramps
- muscle pain or stiffness
- swollen joints
For Healthcare Professionals
Applies to ustekinumab: subcutaneous solution
Respiratory side effects including nasopharyngitis (up to 8%), upper respiratory tract infection (up to 5%), and pharyngolaryngeal pain (up to 2%) have been reported.
Nervous system side effects including headache (5%) and dizziness (2%) have been reported.
Other side effects including cellulitis and other infections have been reported.
In the placebo-controlled period of clinical studies of psoriasis subjects, 27% of ustekinumab-treated subjects reported infections compared with 24% of placebo-treated subjects. Serious infections occurred in 0.3% of ustekinumab-treated subjects and in 0.4% of placebo-treated subjects.
In the controlled and non-controlled portions of psoriasis clinical trials, 72.3% of ustekinumab-treated subjects reported infections. Serious infections were reported in 2.8% of subjects.
General side effects including fatigue (3%) have been reported.
Gastrointestinal side effects including diarrhea (2%) have been reported.
Musculoskeletal side effects including back pain (up to 2%) and myalgia (1%) have been reported.
Local side effects including injection site erythema (up to 2%) and other injection site reactions (pain, swelling, pruritus, induration, hemorrhage, bruising, and irritation) have been reported.
Dermatologic side effects including pruritus (up to 2%) have been reported. Postmarketing reports have included pustular and erythrodermic psoriasis.
Psychiatric side effects have included depression (1%).
In the controlled and non-controlled portions of psoriasis clinical trials 1.7% of ustekinumab (the active ingredient contained in Stelara) treated subjects reported malignancies (excluding non-melanoma skin cancers). Other than non-melanoma skin cancers (1.5%), the most frequently observed malignancies were prostate, colorectal, melanoma in situ, and breast.
Oncologic side effects including malignancies and postmarketing reports of rapidly appearing, multiple cutaneous squamous cell carcinoma have been reported.
Hypersensitivity side effects have included postmarketing reports of serious hypersensitivity reactions (including anaphylaxis and angioedema, and other hypersensitivity reactions (including rash and urticaria).
More Stelara resources
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.